|
Real-time Estimate
Tradegate
10:25:31 2026-08-31 EDT
|
5-day change | 1st Jan Change | ||
| 0.5390 EUR | -1.10% |
|
-11.09% | +28.54% |
| 08-28 | Thor Medical ASA Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 08-28 | Thor Medical ASA, H1 2026 Earnings Call, Aug 28, 2026 |
Company Valuation: Thor Medical
Data adjusted to current consolidation scope
| Fiscal Period: December | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| Market Cap 1 | 737.7 | 1,859 | 2,164 | - | - |
| Change | - | 151.99% | 16.39% | - | - |
| Enterprise Value (EV) 1 | 737.7 | 1,678 | 2,347 | 2,341 | 2,370 |
| Change | - | 127.51% | 39.82% | -0.26% | 1.24% |
| P/E | -14.6x | -30.9x | -42.9x | -54.6x | -85.9x |
| PBR | - | 4.08x | 5.32x | 4.85x | 5.14x |
| PEG | - | 5.56x | 2.4x | 2.5x | 2.4x |
| Capitalization / Revenue | - | 2,216x | 44.2x | 12.9x | 11.8x |
| EV / Revenue | - | 2,000x | 47.9x | 13.9x | 12.9x |
| EV / EBITDA | - | -34.4x | -55.9x | -138x | 2,370x |
| EV / EBIT | - | -24.1x | -34.5x | -44.2x | -74.1x |
| EV / FCF | - | -13.9x | -13.1x | -48.8x | -474x |
| FCF Yield | - | -7.19% | -7.63% | -2.05% | -0.21% |
| Dividend per Share 2 | - | - | - | - | - |
| Rate of return | - | - | - | - | - |
| EPS 2 | -0.18 | -0.17 | -0.14 | -0.11 | -0.07 |
| Distribution rate | - | - | - | - | - |
| Net sales 1 | - | 0.839 | 49 | 168 | 184 |
| EBITDA 1 | - | -48.73 | -42 | -17 | 1 |
| EBIT 1 | - | -69.65 | -68 | -53 | -32 |
| Net income 1 | -42.21 | -58.01 | -49 | -40 | -24 |
| Net Debt 1 | - | -180.6 | 183 | 177 | 206 |
| Reference price 2 | 2.630 | 5.250 | 6.010 | 6.010 | 6.010 |
| Nbr of stocks (in thousands) | 280,492 | 354,077 | 360,002 | - | - |
| Announcement Date | 3/28/25 | 3/27/26 | - | - | - |
1NOK in Million2NOK
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 20.59x | 7.25x | 14.66x | 1.42% | 69.54B | |
| 36.89x | 9.62x | 29.41x | 0.04% | 64.97B | |
| 30.69x | 6.58x | 17.2x | -.--% | 26.51B | |
| -72.56x | 13.98x | -67.43x | -.--% | 25.89B | |
| -15.61x | 5.94x | -7.46x | -.--% | 25.64B | |
| 58.27x | 21.67x | 43.95x | 0.26% | 20.22B | |
| 27.27x | 5.11x | 16.98x | -.--% | 19.98B | |
| 1415.29x | 39.34x | 858.54x | -.--% | 15.69B | |
| 16.84x | 5x | 11.66x | -.--% | 13.49B | |
| Average | 168.63x | 12.72x | 101.95x | 0.19% | 31.33B | |
| Weighted average by Cap. | 94.04x | 10.79x | 57.82x | 0.38% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- NANOV Stock
- 8NN Stock
- Valuation Thor Medical
Select your edition
All financial news and data tailored to specific country editions
